Loyola Medicine oncologist Patrick Stiff, MD, is available to discuss the landmark New England Journal of Medicine study on CAR-T cell therapy for lymphoma (embargoed until Dec. 10 at 10:30 am ET). Dr Stiff, a co-author of the study, offers a more measured evaluation of the benefits and risks of the treatment than some of the other expert commentary that's been published. Dr. Stiff says the treatment, while promising, is not a cure-all.